(Q33182035)

23 July 2017

title

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane (English)

1 reference

23 July 2017

main subject

metastatic breast cancer

1 reference

3

C Seynaeve

1 reference

23 July 2017

Carolien H. Smorenburg

1

object named as

C H Smorenburg

1 reference

23 July 2017

M Bontenbal

2

1 reference

23 July 2017

C van Zuylen

4

1 reference

23 July 2017

G de Heus

5

1 reference

23 July 2017

J Verweij

6

1 reference

23 July 2017

R de Wit

7

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Breast Cancer Research and Treatment

23 July 2017

published in

1 reference

23 July 2017

volume

66

1 reference

23 July 2017

issue

1

1 reference

23 July 2017

page(s)

83-87

1 reference

The role of chemotherapy for metastatic breast cancer

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

The role of gemcitabine in the treatment of other tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Third line chemotherapy in patients with metastatic breast cancer: an evaluation of quality of life and cost.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Advanced breast cancer: a phase II trial with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Phase II study of vinorelbine administered by 96-hour infusion in patients with advanced breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Gemcitabine for palliative treatment in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Gemcitabine in combination with doxorubicin in advanced breast cancer: final results of a phase II pharmacokinetic trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1010679127390

7 January 2021

Identifiers

DOI

10.1023/A:1010679127390

1 reference

Dimensions Publication ID

23 July 2017

1031940077

0 references

1 reference